Ribavirin Export Market Intelligence: India's 50 Suppliers Shipping to 32 Countries — TransData Nexus 2026

Q: Who are the top ribavirin exporters from India?

The top ribavirin exporters from India are: 1. AUROBINDO PHARMA LTD — $521.1K (80.6% market share); 2. AUROBINDO PHARMA LIMITED — $37.5K (5.8% market share); 3. KWALITY PHARMACEUTICALS LIMITED — $15.7K (2.4% market share); 4. EXSELL LABORATORIES PRIVATE LIMITED — $15.2K (2.4% market share); 5. STAR ENTERPRISES — $6.0K (0.9% market share). Together they account for 92.1% of India's total ribavirin export value.

Q: What is the total export value of ribavirin from India?

The total export value of ribavirin from India is $646.4K USD, recorded across 165 shipment transactions from 50 active exporters to 32 destination countries. The average shipment value is $3.9K.

Q: Which countries import ribavirin from India?

India exports ribavirin to 32 countries worldwide. The top importing countries are: UNITED STATES (70.6% share, $456.3K), UNITED KINGDOM (12.2% share, $79.0K), MALTA (4.2% share, $27.2K), MALAYSIA (2.5% share, $16.2K), UGANDA (2.3% share, $15.1K). These five markets account for 91.9% of total export value.

Q: What is the HS code for ribavirin exports from India?

The primary HS code for ribavirin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of ribavirin exports from India?

The average unit price for ribavirin exports from India is $8.51 USD per unit, with prices ranging from $0.06 to $55.91 depending on formulation, packaging, and order volume. The total market is valued at $646.4K across 165 shipments.

Q: Which ports handle ribavirin exports from India?

The primary ports for ribavirin exports from India are SAHAR AIR CARGO ACC (INBOM4) (22.4% of shipments), SAHAR AIR (21.2% of shipments), Bombay Air (13.3% of shipments), DELHI AIR CARGO ACC (INDEL4) (9.7% of shipments), HYDERABAD AIR (7.3% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of ribavirin?

India is one of the world's leading exporters of ribavirin due to its large base of 50 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports ribavirin to 32 countries, demonstrating 16% global market coverage.

Q: What certifications do Indian ribavirin exporters need?

Indian ribavirin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import ribavirin from India?

There are 72 registered buyers importing ribavirin from India, spread across 32 countries. The repeat buyer rate is 45.8%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top ribavirin supplier from India?

AUROBINDO PHARMA LTD is the leading ribavirin exporter from India with a market share of 80.6% and total export value of $521.1K across 28 shipments. The top 5 suppliers together control 92.1% of total export value.

Suresh Sormare

Ribavirin

India Pharmaceutical Trade Intelligence

$646.4K50 Suppliers32 CountriesHS 30049099

ExportsIndia → UNITED STATES70.6%India → UNITED KINGDOM12.2%

ImportsGERMANY → India$282

#1 Buyer: AUROLOGISTICS LLC

Ribavirin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Ribavirin to the World

Between 2022 and 2026, India exported $646.4K worth of ribavirin across 165 verified shipments to 32 countries — covering 16% of world markets in the Antivirals segment. The largest destination is UNITED STATES (70.6%). AUROBINDO PHARMA LTD leads with a 80.6% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·HS 30049099

Ribavirin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Ribavirin export data snapshot — $646.4K · 50 exporters · 32 countriesTransData Nexus · Indian Customs Data

Top Ribavirin Exporters from India

50 active exporters · Ranked by export value

View all 50 →

Top Ribavirin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AUROBINDO PHARMA LTD	$521.1K	28	3	80.6%
2	AUROBINDO PHARMA LIMITED

Top Countries Importing Ribavirin from India

32 destination markets · Ranked by import value

All 32 countries →

Top Countries Importing Ribavirin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	UNITED STATES	$456.3K	70.6%
2	UNITED KINGDOM	$79.0K	12.2%
3	MALTA	$27.2K	4.2%
4	MALAYSIA	$16.2K	2.5%
5	UGANDA	$15.1K	2.3%
6	UNITED ARAB EMIRATES	$12.3K	1.9%
7	NIGERIA	$10.1K	1.6%
8	THAILAND	$9.5K	1.5%
9	IRAN	$5.1K	0.8%
10	BELGIUM	$3.4K	0.5%

UNITED STATES is India's largest ribavirin export destination, absorbing 70.6% of total exports worth $456.3K. The top 5 importing countries — UNITED STATES, UNITED KINGDOM, MALTA, MALAYSIA, UGANDA — together account for 91.9% of India's total ribavirin export value. The remaining 27 destination countries collectively receive the other 8.1%, indicating a focused distribution strategy targeting key markets.

Who Supplies Ribavirin to India?

1 origin countries · Total import value: $282

India imports ribavirin from 1 countries with a combined import value of $282. The largest supplier is GERMANY ($282, 6 shipments), followed by . All values are from Indian Customs (DGFT) import records.

Countries Supplying Ribavirin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	GERMANY	$282	6	100.0%

GERMANY is the largest supplier of ribavirin to India, accounting for 100.0% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Regulatory Landscape — Ribavirin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, ribavirin is approved for the treatment of chronic hepatitis C in combination with other antiviral agents. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for ribavirin, indicating a competitive generic market. Notably, the substantial export volume to the U.S. underscores the importance of Indian manufacturers in supplying this medication. However, the presence of 50 active Indian exporters suggests a highly competitive landscape, necessitating strict adherence to FDA regulations to maintain market access.

The FDA requires that imported pharmaceuticals comply with Current Good Manufacturing Practices (cGMP). Any deviations can result in import alerts, potentially barring products from entering the U.S. market. Therefore, Indian exporters must ensure rigorous quality control and compliance with FDA standards to avoid such regulatory actions.

2EU & UK Regulatory Framework

In the European Union, ribavirin has been authorized for the treatment of chronic hepatitis C. However, several marketing authorizations have been withdrawn in recent years. For instance, the European Commission withdrew the marketing authorization for Ribavirin Teva on June 22, 2021, at the request of the marketing authorization holder, Teva B.V., due to commercial reasons. Similarly, the authorization for Rebetol was withdrawn on October 18, 2023, following the decision of Merck Sharp & Dohme B.V. to permanently discontinue marketing the product for commercial reasons. (ema.europa.eu)

These withdrawals highlight the dynamic nature of the EU pharmaceutical market and the necessity for exporters to stay informed about regulatory changes. Compliance with the European Medicines Agency's (EMA) Good Manufacturing Practice (GMP) guidelines is essential for market access. Additionally, the UK's Medicines and Healthcare products Regulatory Agency (MHRA) maintains similar standards, and post-Brexit, exporters must navigate both EU and UK regulatory landscapes independently.

3WHO Essential Medicines & Global Standards

Ribavirin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its importance in global health. This inclusion facilitates its adoption in national formularies and procurement by international health organizations. Compliance with pharmacopoeial standards such as the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP) is crucial for ensuring product quality and acceptance in various markets.

4India Regulatory Classification

In India, ribavirin is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of the latest updates, ribavirin is not listed under the Drugs (Prices Control) Order (DPCO), implying no ceiling price is currently imposed. For exports, the Directorate General of Foreign Trade (DGFT) mandates a No Objection Certificate (NOC) to ensure compliance with national regulations and to monitor the quality of pharmaceutical exports.

5Patent & Exclusivity Status

The primary patents for ribavirin have expired, leading to a robust generic market. This expiration has enabled numerous manufacturers to produce and export ribavirin, intensifying competition and driving down prices. Consequently, Indian exporters must focus on maintaining high-quality standards and cost-effective production to remain competitive in the global market.

6Recent Industry Developments

In October 2023, the European Commission withdrew the marketing authorization for Rebetol (ribavirin) in the EU at the request of Merck Sharp & Dohme B.V., citing commercial reasons. (ema.europa.eu)

In June 2021, the European Commission withdrew the marketing authorization for Ribavirin Teva Pharma B.V. at the request of Teva B.V., also for commercial reasons. (ema.europa.eu)

These developments reflect a trend of pharmaceutical companies reevaluating the commercial viability of ribavirin in certain markets, potentially impacting global supply chains and pricing structures. Exporters should monitor these trends closely to adapt their strategies accordingly.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Ribavirin

Retail & reference prices across 9 markets vs. India FOB export price of $8.51/unit

Global Price Benchmark for Ribavirin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$10.00	USD	According to the FDA Orange Book, Ribavirin is approved for use in the United States.
United Kingdom	$9.75	GBP	As per the NHS Drug Tariff, Ribavirin is listed for use in the UK.
Germany	$8.80	EUR	The European Medicines Agency (EMA) includes Ribavirin in its list of approved medications.
Australia	$8.40	AUD

Supply Chain Risk Assessment — Ribavirin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Ribavirin, an antiviral medication, relies on Active Pharmaceutical Ingredients (APIs) that are predominantly manufactured in India. However, the production of these APIs is heavily dependent on Key Starting Materials (KSMs) and intermediates imported from China. According to the U.S. Pharmacopeia's Medicine Supply Map, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting a significant supply chain vulnerability.

This dependency has been exposed during recent disruptions. For instance, in July 2018, environmental regulations led to the shutdown of numerous chemical plants in China, causing a substantial increase in the prices of KSMs and intermediates. This, in turn, impacted Indian API manufacturers, leading to higher production costs and potential supply constraints.

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that the top five exporters account for 92.1% of Ribavirin exports from India, with AUROBINDO PHARMA LTD alone contributing 80.6%. This high supplier concentration poses a significant single-source risk. Any operational or regulatory issues affecting these key suppliers could disrupt the global supply of Ribavirin.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce reliance on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules like Penicillin G and 6-APA, marking a significant step towards self-sufficiency in API production.

Access Complete Ribavirin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 165 transactions across 32 markets.

Request Demo View Pricing

Frequently Asked Questions — Ribavirin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top ribavirin exporters from India?

The leading ribavirin exporters from India are AUROBINDO PHARMA LTD, AUROBINDO PHARMA LIMITED, KWALITY PHARMACEUTICALS LIMITED, and 6 others. AUROBINDO PHARMA LTD leads with 80.6% market share ($521.1K). The top 5 suppliers together control 92.1% of total export value.

What is the total export value of ribavirin from India?

The total export value of ribavirin from India is $646.4K, recorded across 165 shipments from 50 active exporters to 32 countries. The average shipment value is $3.9K.

Which countries import ribavirin from India?

India exports ribavirin to 32 countries. The top importing countries are UNITED STATES (70.6%), UNITED KINGDOM (12.2%), MALTA (4.2%), MALAYSIA (2.5%), UGANDA (2.3%), which together account for 91.9% of total export value.

What is the HS code for ribavirin exports from India?

The primary HS code for ribavirin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Ribavirin

Ribavirin

Top Ribavirin Exporters from India

Top Countries Importing Ribavirin from India

Who Supplies Ribavirin to India?

Quick Facts

Related Antivirals

Related Analysis

Need Details?

Regulatory Landscape — Ribavirin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Ribavirin

Supply Chain Risk Assessment — Ribavirin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Ribavirin Trade Intelligence

Frequently Asked Questions — Ribavirin Exports from India

Who are the top ribavirin exporters from India?

What is the total export value of ribavirin from India?

Which countries import ribavirin from India?

What is the HS code for ribavirin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of ribavirin exports from India?

Which ports handle ribavirin exports from India?

Why is India a leading exporter of ribavirin?

What certifications do Indian ribavirin exporters need?

How many buyers import ribavirin from India?

What is the market share of the top ribavirin exporter from India?

Analysis Methodology